Clinical Trials Unplugged: Annual Drug Safety Update (Sponsored by the ReST Committee)
10/26/2022 7:30 pm – 8:30 pm
Peter Kaiser, MD, Andre Witkin, MD, Caroline Baumal, MD, Eric Schneider, MD, Ali Fehrina, MD, Henry Leder, MD, J. Fernando Arevalo, MD, Lejla Vajzovic, MD, Netan Choudhry, MD, Nieral Jain, MD, R. Goldberg, MD, R. Vora, MD, Y. Yonekawa, MD
1 Professional Development Credits
The program will include:
- Update on faricimab and ranibizumab PDS
- Safety issues with 1.25% pilocarpine (Vuity™, Allergan/Abbvie)
- Biosimilars in retina
- Complement Inhibition Phase 3 discussion
- Discussion of other issues seen by the ReST Committee and ASRS members
Accreditation Statement and CME Credit
The American Society of Retina Specialists is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
The American Society of Retina Specialists designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.